These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
754 related articles for article (PubMed ID: 1359541)
1. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541 [TBL] [Abstract][Full Text] [Related]
3. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299 [TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Muller WJ; Arteaga CL; Muthuswamy SK; Siegel PM; Webster MA; Cardiff RD; Meise KS; Li F; Halter SA; Coffey RJ Mol Cell Biol; 1996 Oct; 16(10):5726-36. PubMed ID: 8816486 [TBL] [Abstract][Full Text] [Related]
5. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland. Bradbury JM; Arno J; Edwards PA Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220 [TBL] [Abstract][Full Text] [Related]
11. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
12. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493 [TBL] [Abstract][Full Text] [Related]
13. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI; Leder P Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125 [TBL] [Abstract][Full Text] [Related]
14. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
15. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Bouchard L; Lamarre L; Tremblay PJ; Jolicoeur P Cell; 1989 Jun; 57(6):931-6. PubMed ID: 2567634 [TBL] [Abstract][Full Text] [Related]
16. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu. Elson A; Leder P J Biol Chem; 1995 Nov; 270(44):26116-22. PubMed ID: 7592814 [TBL] [Abstract][Full Text] [Related]
18. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933 [TBL] [Abstract][Full Text] [Related]
19. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Muthuswamy SK; Muller WJ Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608 [TBL] [Abstract][Full Text] [Related]
20. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]